Citius Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy and unique prescription products.
Citius Pharmaceuticals has raised $49.8M across 10 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Apr 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Citius Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Citius Pharmaceuticals Funding Rounds
Citius Pharmaceuticals raised $2.4M in an undisclosed round announced in Mar 2024.
8 months later, an undisclosed round of $3.0M was announced in Nov 2024.
2 months later, an undisclosed round of $3.0M was announced in Jan 2025.
3 months later, an undisclosed round of $2.0M was announced in Apr 2025.
2 months later, an undisclosed round of $6.0M was announced in Jun 2025.
4 months later, an undisclosed round of $6.0M was announced in Oct 2025.
4 months later, an undisclosed round of $3.8M was announced in Feb 2026.
2 months later, an undisclosed round of $5.0M was announced in Apr 2026.
Citius Pharmaceuticals Founders and Leadership Team
Contact details for the Citius Pharmaceuticals team: 1 of 2 have an email address on file.
Start 14-day free trial →Citius Pharmaceuticals Funding Compared to Other Biotechnology Startups
Citius Pharmaceuticals' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Citius Pharmaceuticals in Biotechnology and Cranford
Companies Similar to Citius Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Citius Pharmaceuticals Funding FAQs
What does Citius Pharmaceuticals do?
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy and unique prescription products.
How much funding has Citius Pharmaceuticals raised?
Citius Pharmaceuticals has raised $49.8M across 10 rounds on record. The most recent is an undisclosed round of $5.0M announced in Apr 2026.
When did Citius Pharmaceuticals last raise funding?
Citius Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.0M, announced in Apr 2026.
Who founded Citius Pharmaceuticals?
FundedIQ lists Leonard Mazur (Founder) at Citius Pharmaceuticals.
Who is the CEO of Citius Pharmaceuticals?
Myron Holubiak is listed as CEO at Citius Pharmaceuticals.
Where is Citius Pharmaceuticals headquartered?
Citius Pharmaceuticals is based in Cranford, New Jersey, United States.
How many employees does Citius Pharmaceuticals have?
Citius Pharmaceuticals is in the 11-50 employee band.
How does Citius Pharmaceuticals' funding compare to other Biotechnology startups?
Citius Pharmaceuticals' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Citius Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Citius Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.